PTC Therapeutics Inc (PTCT) — Capital Reinvestment Ratio
Latest as of March 2025:
0.00x
PTC Therapeutics Inc (PTCT) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($870.10 Million) in capital expenditures ($2.53 Million). See PTCT free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$870.10 Million
USD
Capital Expenditures
$2.53 Million
USD
Data as of
Mar 2025
Most recent filing
PTC Therapeutics Inc Capital Reinvestment Ratio (2025–2025)
This chart tracks PTC Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for PTC Therapeutics Inc (2025–2025)
Year-by-year Capital Reinvestment Ratio for PTC Therapeutics Inc from 2025 to 2025. For live market cap and broader valuation context, see how much is PTC Therapeutics Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $711.20 Million | $8.86 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow